These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The use of prophylactic eye drops during high-dose cytosine arabinoside therapy.
    Author: Higa GM, Gockerman JP, Hunt AL, Jones MR, Horne BJ.
    Journal: Cancer; 1991 Oct 15; 68(8):1691-3. PubMed ID: 1913509.
    Abstract:
    An ocular toxic reaction presenting as conjunctivitis or keratitis develops in a significant number of patients who are treated with high-dose cytosine arabinoside (ara-C). Although eye drops containing glucocorticoid reportedly decrease the incidence, they do not totally eliminate this side effect. In comparing this technique with artificial tears, both were found to be equally effective. The primary mechanism by which eye drops decrease ocular toxic reactions associated with high-dose ara-C is presumably due to dilution of intraocular concentrations of ara-C.
    [Abstract] [Full Text] [Related] [New Search]